MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Platelet-rich therapy (PRP) is being used in surgeries to promote cell regeneration since 1987. The procedure involves taking the patient’s own blood, processing it in the laboratory to concentrate the platelets, and injecting the platelets into the body. What are platelets? Platelets are fragments of
Regenerative therapies for the musculoskeletal system are the future of orthopedic medicine. Stem cell therapy is an innovative treatment that heals musculoskeletal problems without the need for surgery. In the United States alone, there are more than 500,000 spinal fusions and 400,000 lumbar discectomies performed
Stem cell therapy is often acknowledged as a treatment to be used in lieu of other types of procedures, such as surgery. However, it’s been noted that at times it may not be a situation that calls for an either/or choice. There are various types
Amniotic stem cell material is harvested from the amniotic sac after a scheduled C-Section. The baby is fine and no embryonic stem cells are involved. In addition, the woman is consented and compensated. While some people may have ethical issues with embryonic stem cell therapy,
A small number of stem cells taken from the body can grow in the laboratory setting to create millions of new stem cells. Known as regenerative medicine, stem cell-based therapies hold the promise of replacing and repairing damaged and disease body structures. What ethical issues
Amniotic fluid is highly concentrated in proteins, cytokines, stem cells, and other components that are useful for the boy. Clinical studies show that amniotic fluid and stem cells have many benefits. What are amniotic stem cells? Amniotic fluid is the fluid that surrounds the fetus
Platelet rich plasma (PRP) therapy is being utilized increasingly to help enhance and encourage the healing process for those who have soft tissue and bone injuries. PRP has received increased attention from the media as it has been used to help high profile athletes who
What is a Diabetic Foot Ulcer? People who suffer from diabetes are at risk of developing ulcers on their feet. Diabetic foot ulcers affect up to 15 percent of diabetic patients, and over 80 percent of lower leg amputations are done in the treatment of
The Achilles tendon is a common point of vulnerability for athletes in particular, whether professional, collegiate, or the weekend recreational dilettante. When it is strained, there is no thought of continuing activity until it rests. If the tendon tears, walking off the field is an
